BL L1 (Lysodren 500 mg)
Generic Name: mitotane
Pill imprint BL L1 has been identified as Lysodren 500 mg.
Lysodren is used in the treatment of adrenal cortical carcinoma and belongs to the drug class miscellaneous antineoplastics. There is positive evidence of human fetal risk during pregnancy. Lysodren 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- mitotane
- Imprint:
- BL L1
- Strength:
- 500 mg
- Color:
- White
- Size:
- 13.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antineoplastics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00015-3080
- Inactive Ingredients:
- microcrystalline cellulose
polyethylene glycol 3350
silicon dioxide
Note: Inactive ingredients may vary.
More about Lysodren (mitotane)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous antineoplastics
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
